Skip to main content


GoodRx IPO shows low drug prices can still mean big money

By Forbes  
   September 24, 2020

Shares of drug pricing company GoodRx soared on Wednesday, up 53% from its initial IPO list price of $33 at market close. The company best known for its drug discount coupons is also cashing in on the virtual care boom set off by the Covid-19 pandemic through its telemedicine services.

Full story

Get the latest on healthcare leadership in your inbox.